Patent application number | Description | Published |
20110278360 | FOCUS ADJUSTMENT WITH LIQUID CRYSTAL DEVICE IN IMAGING SCANNER - A method and apparatus for using in an imaging scanner. The apparatus includes an illumination source, a solid-state imager, a liquid crystal device, a lens system, and a decoding circuitry. The liquid crystal device has a liquid crystal material sandwiched between two parallel plate structures. The lens system is operative to focus light reflected from the target object onto the array of photosensitive elements in the solid-state imager through the liquid crystal device. The decoding circuitry is operative to decode a barcode on the target object from the image captured by the solid-state imager. | 11-17-2011 |
20110315772 | FOCUS ADJUSTMENT WITH MEMS ACTUATOR IN IMAGING SCANNER - A method and apparatus for using in an imaging scanner. The apparatus includes a solid-state imager, an imaging lens assembly comprising a base lens and a MEMS lens, and an electric circuitry operative to transfer the image captured by the solid-state imager to a decoding circuitry. The imaging lens assembly is configured to focus light reflected from the target object onto the array of photosensitive elements in the solid-state imager by passing the light reflected from the target object through the base lens followed by the MEMS lens. | 12-29-2011 |
20130334314 | AIMING SYSTEM FOR IMAGING SCANNER - An apparatus includes (1) an imaging lens arrangement having an optical axis, (2) an aiming light source configured to project visible light through the imaging lens arrangement to create an aiming pattern on a target object, (3) an imaging sensor detecting light from the target object through the imaging lens arrangement, and (4) a folding mirror tilted relative to the optical axis of the imaging lens arrangement. The folding mirror is positioned both on the optical path from the imaging lens arrangement to the imaging sensor and on the optical path from the aiming light source to the imaging lens arrangement. Both the imaging arrangement and the aiming arrangement share the same imaging lens. | 12-19-2013 |
20130334315 | ILLUMINATION SYSTEM WITH PRISM FOR USE IN IMAGING SCANNER - An apparatus includes an illumination lens, an illumination light source for generating illumination light, and a prism made of optical transparent material. The first section on the first surface of the prism has a length that is at least four times as long as its width. The first surface of the prism includes a second section adjacent to the first section for defining the edge of an aperture. The third surface of the prism is configured to reflect the illumination light received from the first section onto the second surface of the prism. At least a portion of the illumination light received from the first section passes through both the second surface of the prism and the illumination lens for projecting illumination light onto a target object within an imaging field of view. | 12-19-2013 |
20140144987 | BI-OPTICAL BARCODE SCANNING WORKSTATION WITH STITCHED SAPPHIRE WINDOWS - The method of constructing a bi-optical workstation for imaging barcodes includes forming a window sheet by joining at least four rectangular-shaped sapphire sheets together with the area of the window sheet substantially equal to the sum of the areas of the at least four rectangular-shaped sapphire sheets. The method also includes constructing a first window on the housing with the first window located in a generally horizontal plane and constructing a second window on the housing with the second window located in a generally upright plane that intersects the generally horizontal plane. At least one of the first window and the second window comprises the window sheet formed by the at least four rectangular-shaped sapphire sheets. | 05-29-2014 |
20150371070 | EFFICIENT OPTICAL ILLUMINATION SYSTEM AND METHOD FOR AN IMAGING READER - A target to be read by image capture is illuminated with an illumination light pattern by an illuminating light assembly having an enhanced optical coupling efficiency. The assembly includes a hybrid lens component having a first lens portion centered on an optical axis, and a second total internal reflection (TIR) lens portion surrounding the first lens portion about the optical axis. Both lens portions intercept, bend and collimate illumination light emitted from a light emitting diode. The collimated light is incident on a lenslet component having an array of lenslets generally arranged in a plane that is generally perpendicular to the optical axis. | 12-24-2015 |
Patent application number | Description | Published |
20100021476 | High Affinity Human Antibodies to Human IL-4 Receptor - The present invention provides methods for treating one or more diseases or disorders which are improved, inhibited or ameliorated by reducing interleukin-4 (IL-4) activity. The methods of the invention comprise administering to a patient an antibody, or antigen-binding fragment thereof, which specifically binds to a human IL-4 receptor. | 01-28-2010 |
20100291107 | HIGH AFFINITY HUMAN ANTIBODIES TO HUMAN IL-4 RECEPTOR - The present invention provides methods for treating one or more diseases or disorders which are improved, inhibited or ameliorated by reducing interleukin-4 (IL-4) activity. The methods of the invention comprise administering to a patient an antibody, or antigen-binding fragment thereof, which specifically binds to a human IL-4 receptor. | 11-18-2010 |
20120135010 | HIGH AFFINITY HUMAN ANTIBODIES TO HUMAN IL-4 RECEPTOR - An isolated human antibody or antigen binding fragment thereof which binds to human interleukin-4 receptor alpha (hIL-4Rα) with an affinity constant (K | 05-31-2012 |
20150266976 | VL ANTIGEN BINDING PROTEINS EXHIBITING DISTINCT BINDING CHARACTERISTICS - Methods for making, identifying, isolating and/or making binding proteins that contain an immunoglobulin light chain variable domain, including a somatically hypermutated light chain variable domain, fused with a heavy chain constant region, are provided. Exemplary binding proteins specific to small molecules are also provided. | 09-24-2015 |
Patent application number | Description | Published |
20090197271 | FUNCTIONAL NUCLEIC ACID LIGANDS TO FLUORESCENT PROTEINS - The present invention relates to a nucleic acid aptamer having a first domain that binds to a fluorescent protein. The nucleic acid aptamer forms a molecular complex whereby the aptamer binds a fluorescent protein at the first domain. A constructed DNA molecule, expression systems, and host cells containing the molecular complex are also disclosed. The invention also relates to a system containing a first DNA molecule encoding the nucleic acid aptamer of the present invention and a second DNA molecule encoding a fluorescent protein capable of being bound by the first domain. Methods of detecting a molecular target and determining location of a molecular target using the nucleic acid aptamer of the invention are also disclosed. | 08-06-2009 |
20100099749 | Nucleic Acid Inhibitors Of Glutamate Receptors - The present invention relates to novel nucleic acid ligands or aptamers that bind to and inhibit the activation of the α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) subtype of ionotropic glutamate receptors. Also disclosed is a novel combination of technologies, i.e., SELEX and laser pulse photolysis for the selection and screening of aptamers that inhibit receptor function and are useful therefore, in the treatment of diseases associated with excessive activation of ionotropic glutamate receptors. | 04-22-2010 |
20120141382 | APTAMER MODULATORS OF COMPLEMENT PROTEIN C3 AND BIOLOGICALLY ACTIVE PROTEOLYTIC PRODUCTS THEREOF - This invention relates to nucleic acid aptamers that recognize and bind the complement protein C3 or its biologically active proteolytic products and methods of their use. Particularly preferred are bi-functional aptamer construct that binding specifically with C3b or iC3b, and another target protein. Use of these molecular constructs for commandeering the opsonization process is also described herein. | 06-07-2012 |
20120225929 | Nucleic Acid Inhibitors Of Glutamate Receptors - The present invention relates to novel nucleic acid ligands or aptamers that bind to and inhibit the activation of the α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) subtype of ionotropic glutamate receptors. Also disclosed is a novel combination of technologies, i.e., SELEX and laser pulse photolysis for the selection and screening of aptamers that inhibit receptor function and are useful therefore, in the treatment of diseases associated with excessive activation of ionotropic glutamate receptors. | 09-06-2012 |
20150031754 | APTAMER MODULATORS OF ESTROGEN RECEPTORS - The present invention relates to a nucleic acid aptamer molecule that includes a domain that binds to an estrogen receptor, molecular complexes that include the nucleic acid aptamer molecule and an estrogen receptor, and constructed DMA molecules and expression systems, as well as host cells, that the contain an RNA aptamer molecule of the invention. Use of these aptamers and encoding constructs to inhibiting estrogen receptor activity in a cell and to treat estrogen receptor-positive cancers is also described. | 01-29-2015 |
Patent application number | Description | Published |
20100151524 | Compositions and Methods for Increasing Bone Mineralization - A novel class or family of TGF-β binding proteins is disclosed. Also disclosed are assays for selecting molecules for increasing bone mineralization and methods for utilizing such molecules. In particular, compositions and methods relating to antibodies that specifically bind to TGF-beta binding proteins are provided. These methods and compositions relate to altering bone mineral density by interfering with the interaction between a TGF-beta binding protein sclerostin and a TGF-beta superfamily member, particularly a bone morphogenic protein. Increasing bone mineral density has uses in diseases and conditions in which low bone mineral density typifies the condition, such as osteopenia, osteoporosis, and bone fractures. | 06-17-2010 |
20110195453 | Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization - Compositions and methods relating to antibodies that specifically bind to TGF-beta binding proteins are provided. These methods and compositions relate to altering bone mineral density by interfering with the interaction between a TGF-beta binding protein sclerostin and a TGF-beta superfamily member, particularly a bone morphogenic protein. Increasing bone mineral density has uses in diseases and conditions in which low bone mineral density typifies the condition, such as osteopenia, osteoporosis, and bone fractures. | 08-11-2011 |
20110206677 | ANTIBODIES SPECIFIC FOR SCLEROSTIN AND METHODS FOR INCREASING BONE MINERALIZATION - Compositions and methods relating to antibodies that specifically bind to TGF-beta binding proteins are provided. These methods and compositions relate to altering bone mineral density by interfering with the interaction between a TGF-beta binding protein sclerostin and a TGF-beta superfamily member, particularly a bone morphogenic protein. Increasing bone mineral density has uses in diseases and conditions in which low bone mineral density typifies the condition, such as osteopenia, osteoporosis, and bone fractures. | 08-25-2011 |
20110206678 | Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization - Compositions and methods relating to antibodies that specifically bind to TGF-beta binding proteins are provided. These methods and compositions relate to altering bone mineral density by interfering with the interaction between a TGF-beta binding protein sclerostin and a TGF-beta superfamily member, particularly a bone morphogenic protein. Increasing bone mineral density has uses in diseases and conditions in which low bone mineral density typifies the condition, such as osteopenia, osteoporosis, and bone fractures. | 08-25-2011 |
20110262443 | Epitopes Of Il-17a And Il-17f And Antibodies Specific Thereto - The present invention relates neutralising epitopes of IL-17A and IL-17F and antibodies which bind those epitopes. The present invention also relates to the therapeutic uses of the antibody molecules and methods for producing them. | 10-27-2011 |
20120321636 | ANTIBODIES SPECIFIC FOR SCLEROSTIN AND METHODS FOR INCREASING BONE MINERALIZATION - Compositions and methods relating to antibodies that specifically bind to TGF-beta binding proteins are provided. These methods and compositions relate to altering bone mineral density by interfering with the interaction between a TGF-beta binding protein sclerostin and a TGF-beta superfamily member, particularly a bone morphogenic protein. Increasing bone mineral density has uses in diseases and conditions in which low bone mineral density typifies the condition, such as osteopenia, osteoporosis, and bone fractures. | 12-20-2012 |
20130064829 | Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization - Compositions and methods relating to antibodies that specifically bind to TGF-beta binding proteins are provided. These methods and compositions relate to altering bone mineral density by interfering with the interaction between a TGF-beta binding protein sclerostin and a TGF-beta superfamily member, particularly a bone morphogenic protein. Increasing bone mineral density has uses in diseases and conditions in which low bone mineral density typifies the condition, such as osteopenia, osteoporosis, and bone fractures. | 03-14-2013 |
20130064830 | Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization - Compositions and methods relating to antibodies that specifically bind to TGF-beta binding proteins are provided. These methods and compositions relate to altering bone mineral density by interfering with the interaction between a TGF-beta binding protein sclerostin and a TGF-beta superfamily member, particularly a bone morphogenic protein. Increasing bone mineral density has uses in diseases and conditions in which low bone mineral density typifies the condition, such as osteopenia, osteoporosis, and bone fractures. | 03-14-2013 |
20140193403 | Epitopes of IL-17A and IL-17F and Antibodies Specific Thereto - The present invention relates neutralising epitopes of IL-17A and IL-17F and antibodies which bind those epitopes. The present invention also relates to the therapeutic uses of the antibody molecules and methods for producing them. | 07-10-2014 |
20150191537 | ANTIBODIES SPECIFIC FOR SCLEROSTIN AND METHODS FOR INCREASING BONE MINERALIZATION - Compositions and methods relating to antibodies that specifically bind to TGF-beta binding proteins are provided. These methods and compositions relate to altering bone mineral density by interfering with the interaction between a TGF-beta binding protein sclerostin and a TGF-beta superfamily member, particularly a bone morphogenic protein. Increasing bone mineral density has uses in diseases and conditions in which low bone mineral density typifies the condition, such as osteopenia, osteoporosis, and bone fractures. | 07-09-2015 |
20150315272 | Epitopes of IL-17A and IL-17F And Antibodies Specific Thereto - The present invention relates neutralising epitopes of IL-17A and IL-17F and antibodies which bind those epitopes. The present invention also relates to the therapeutic uses of the antibody molecules and methods for producing them. | 11-05-2015 |
Patent application number | Description | Published |
20100279400 | DIAGNOSTIC TEST FOR WEST NILE VIRUS - The present invention provides a rapid and sensitive method for the detection of a West Nile virus (WNV), Japanese encephalitis virus (JEV), St. Louis encephalitis virus (SLEV) and Dengue virus (DENV) and antibodies directed against thereof involving contacting a biological specimen suspected of being infected with WNV, JE, SLE or DEN with a substantially purified and isolated WNV E glycoprotein or subfragment thereof having a native conformation wherein the E glycoprotein or subfragment thereof has a reactivity with antibodies against WNV and a cross-reactivity with antibodies against JEV, SLEV and DENV. The instant invention further provides a rapid, sensitive, and consistent method for the specific detection of WNV by employing diagnostic assays having the antigen NS5 which is specifically reactive with anti-WNV antibodies but not cross-reactive with antibodies against other flaviviruses such as JEV, SLEV, or DENV. The present invention also provides a rapid, sensitive, and consistent method for the specific detection of DENV by employing diagnostic assays having the antigen NS5 which is specifically reactive with anti-DENV antibodies but do not cross-react with antibodies against other flaviviruses such as JEV, SLEV, or WNV. Further, the DENV NS5 antigens are serospecific and do not cross react with antibodies to other DENV strains. Thus, the method of the present invention provides a manner by which to discriminate infections by each DENV strain. Further, diagnostic kits for carrying out the methods are provided. The methods and kits for carrying out the methods of the invention are rapid and require as little as 10 minutes to detect a result. The invention also provides monoclonal antibodies against WNV NS5 and DENV NS5 antigen and their use in detecting WNV and DENV infections in a biological sample. | 11-04-2010 |
Patent application number | Description | Published |
20090064581 | PLASMA-ASSISTED WASTE GASIFICATION SYSTEM - A plasma-assisted waste gasification system and process for converting waste stream reaction residues into a clean synthesis gas (syngas) is disclosed. The feedstock is fed into a reactor roughly one-third from the bottom through the use of a feed mechanism. The reactor has three zones; a bottom zone where melting occurs, a middle zone where gasification takes place, and a top zone with integrated plasma torches to control the temperature and polish the syngas. The residence times in the three zones are selected to optimize the syngas composition and melted products. The syngas leaves the reactor and is partially quenched with relatively cooler synthesis gas. The partially quenched syngas is further cooled to recover heat for steam generation and/or preheating the waste stream to the reactor. The cold syngas is then processed to remove pollutants. The clean synthesis gas is combusted in power generation equipment to generate electricity, or converted to other fuels by chemical processes. | 03-12-2009 |
20090263245 | SYSTEMS AND METHODS INVOLVING WIND TURBINE TOWERS FOR POWER APPLICATIONS - A system for determining wind turbine tower base torque loads including a controller configured to determine a torque load of a base of a tower of a wind turbine according to a computation of an effective height of the wind turbine multiplied by a wind force upon a rotor of the wind turbine, and generate a control signal representing the torque load. A method for determining wind turbine tower base torque loads including determining a torque load of a base of a tower of a wind turbine according to the foregoing computation, and generating a control signal representing the torque load. | 10-22-2009 |
20100187184 | METHODS AND SYSTEMS FOR ENERGY EXCHANGE - Methods and systems for energy recovery in desalination or other systems are provided to transfer the pressure energy from one fluid to anther fluid. A system for energy recovery with a container comprises two sections separated by one or plurality of flexible impermeable diaphragms and pressures of the two fluids in the two sections are transmitted during the cyclical filling and pumping operations, as well as flow control valves. As one embodiment, two flexible impermeable tubes operable to receive two fluids of different pressures respectively connect to flow control valves. The first fluid and the second fluid are separated by the flexible impermeable diaphragm formed by the flexible tubes. Cyclical inflows of the two fluids transmit the higher pressure of one fluid to the other through the diaphragm and transfer the energy from one fluid to the other. | 07-29-2010 |
20110146232 | CONTROL SYSTEM FOR A PULSE DETONATION TURBINE ENGINE - A pulse detonation turbine engine (PDTE) includes at least one controllable multi-tube pulse detonation combustor (PDC) configured to initiate firing of one or more pulse detonation tubes in response to operation of a plurality of controllable peripheral PDC components to regulate PDTE output characteristics. A control system including a programmable controller directed by algorithmic software operates to generate control inputs for the plurality of controllable peripheral PDC components in response to PDTE input conditions, such that one or more PD tube controllable inputs can be different for at least one PD tube relative to another PD tube within the multi-tube PDC, and further such that detonation timing can be different for at least one PD tube relative to another PD tube within the multi-tube PDC. | 06-23-2011 |
20110290637 | SENSING AND CONTROL FOR PLASMA-ASSISTED WASTE GASIFICATION - A plasma-assisted waste gasification system including a sensing mechanism and process for converting waste stream reaction residues into a clean synthesis gas (syngas) is disclosed. The gasification system includes a first sensor located between a gas quench unit and a heat recovery unit to measure a first temperature and first flow rate of the synthesis gas exiting the gas quench unit; a second sensor to measure a second temperature and a second flow rate of a low temperature synthesis gas entering the gas quench unit; wherein the first sensor and the second sensor are connected to an inferential sensing mechanism. The inferential sensing mechanism is capable of estimating the temperature of the synthesis gas in the reactor, based on the measured first temperature and first flow rate, and the measured second temperature and second flow rate, using a mass-energy balance relationship that is based on the measurements of the two sensors. Another aspect of the invention relates to a control unit to control the temperature of the reactor to a required operating temperature range. | 12-01-2011 |
20130138279 | SYSTEM AND METHOD FOR ENERGY MANAGEMENT IN AN ELECTRIC VEHICLE - A vehicular energy management system (EMS) determines a net total power from a traction drive load, an auxiliary device load, and a regenerative power. If the net total power is a net supply power, the EMS causes regenerative power to be provided to a power source and energy source in a controlled manner to initially charge the power source to a desired state-of-charge (SOC) and then subsequently charge the energy source. If the net total power comprises a net power load, the EMS causes power to be drawn from the power source and the energy source, with a split of the power being drawn from the power source and the energy source being based on a magnitude of the net power load. The EMS adjusts/maintains the SOC set-point of the power source and the DC link voltage based on vehicle speed and relative altitude of travel of the vehicle. | 05-30-2013 |
Patent application number | Description | Published |
20100268072 | METHOD AND APPARATUS FOR POSITIONAL TRACKING OF THERAPEUTIC ULTRASOUND TRANSDUCER - A therapeutic ultrasound tracking system ( | 10-21-2010 |
20100332250 | PRE-EXAMINATION MEDICAL DATA ACQUISITION SYSTEM - A pre-examination patient information gathering system comprises an electronic user interface ( | 12-30-2010 |
20110020236 | METHOD FOR THE SYNTHESIS OF HOLLOW SPHERES - The present invention relates to a method of synthesizing acoustically active biodegradable hollow spheres with a size below 1 micron. By using water soluble organic solvents and pegylated polymers, direct precipitation of these spheres is facilitated leading to a fast and convenient preparation route. | 01-27-2011 |
20110125080 | ULTRASOUND MEDIATED DRUG DELIVERY - Described is a method for the delivery of a therapeutic agent to a mammal, particularly a human person, comprising (i) the administration of ultrasound particles that undergo a physical change when subjected to ultrasound; (ii) the administration of the therapeutic agent in an ultrasound dosage form allowing release of the therapeutic agent to be affected by the application of ultrasound, (iii) the application of ultrasound so as to affect a physical change in at least some of the ultrasound particles, and (iv) the application of ultrasound so as to stimulate release of the therapeutic agent. According to the invention the ultrasound particles are subjected to detection of their acoustic responses via echoes and/or emissions. The information thus obtained is processed and the processed information is used to adapt or adjust the ultrasound-mediated delivery of the therapeutic agent. This can be carried out using a single set of particles (that serve both as ultrasound imaging tracers and as drug delivery vehicles) or by applying separate sets of particles. | 05-26-2011 |
20120143058 | PROPAGATION-MEDIUM-MODIFICATION-BASED REVERBERATED-SIGNAL ELIMINATION - Acquired echo data is corrected to reduce content from ultrasound that has undergone at least one reflection off the probe surface, for example, to reduce corresponding reverberation artefacts from imaging. In some embodiments, the propagation medium, i.e., layer or adjoining layers, through which the reverberation occurs, is, after a set of echo radiofrequency data ( | 06-07-2012 |
20120165670 | CONTRALATERAL ARRAY BASED CORRECTION OF TRANSCRANIAL ULTRASOUND ABERRATION - Ultrasound aberration, especially in transcranial imaging or therapy, is corrected by capturing the laterally two-dimensional nature of the aberration in the ultrasound being received, as by means of a two-dimensional receiving transducer array ( | 06-28-2012 |
20120203103 | PHOTOACOUSTIC CONTRAST AGENT BASED ACTIVE ULTRASOUND IMAGING - Electromagnetic energy is applied to thereby oscillate a bubble that is then insonified to produce an echo ( | 08-09-2012 |
20130041252 | ULTRASONIC TRACKING OF ULTRASOUND TRANSDUCER(S) ABOARD AN INTERVENTIONAL TOOL - In one aspect, an ultrasound receive beamformer ( | 02-14-2013 |
20130281848 | PHOTO-ACOUSTIC SIGNAL ENHANCEMENT WITH MICROBUBBLE-BASED CONTRAST AGENTS | 10-24-2013 |
20150297176 | ULTRASOUND HEAD FRAME FOR EMERGENCY MEDICAL SERVICES - A head frame is configured for the head of a medical patient ( | 10-22-2015 |
20160000411 | CONSISTENT SEQUENTIAL ULTRASOUND ACQUISITIONS FOR INTRA-CRANIAL MONITORING - A medical imaging probe ( | 01-07-2016 |
Patent application number | Description | Published |
20110080823 | DISC STRUCTURE FOR BIT-WISE HOLOGRAPHIC STORAGE - An optical article is provided. The optical article includes a first layer. The first layer includes an active holographic layer configured to store holographic data. The first layer has a first surface and a second surface. A second layer includes a low birefringence material. The second layer also has a first surface and a second surface. Guide grooves are present in any one of the first layer or the second layer. In certain embodiments, the article may further include a reflective layer, an anti-reflective layer, a barrier layer, and a combination thereof. | 04-07-2011 |
20120134251 | SYSTEM AND METHOD FOR PRECISE SERVOING - A method for servoing when reading out a recorded holographic disk or recording in a preformatted holographic disk is disclosed. The method includes detecting a primary signal of a reflected primary beam from a target data track of a target data layer of the holographic disk, wherein the primary beam of radiation has a first wavelength. The method also includes comparing a power measurement of the primary signal with a threshold value of power. The method also includes detecting a tracking signal of a reflected tracking beam from a reference layer of the holographic disk in an event that the power measurement of the primary signal is below the threshold value of power, wherein the tracking beam of radiation has a second wavelength. The method also includes generating a servo error signal based upon the primary signal or the tracking signal. The method further includes actuating an optical sub-system based upon either of the primary servo error signal or the tracking servo error signal such that the primary beam focuses on the target data layer. | 05-31-2012 |
20140036328 | STACKED FILM THRESHOLD COMPONENT, DEVICE, AND METHOD OF MANUFACTURE - A component includes a micro-hologram layer, where the micro-hologram layer includes layers inert to light interleaved with layers of functional film. The functional film layers are made of a material that undergoes a change in its refractive index when illuminated by a light beam, yet undergoes no change in its refractive index when illuminated by a different light beam. The components may further include interleaved spacer films with multiple micro-hologram layers and other elements (e.g., servo layer, coatings, and the like) so as to comprise a data storage device. Methods of manufacturing the component and device are also disclosed. | 02-06-2014 |
Patent application number | Description | Published |
20100259832 | ADJUSTABLE LENS SYSTEM FOR REAL-TIME APPLICATIONS - An adjustable fluid type lens system is provided that allows e.g. ultrasound imaging through the lens during adjustment of the lens. The lens includes a container enclosing two immiscible fluids, e.g. water and oil, being in contact with each other at an interface. Incoming waves are then refracted at this interface. The shape of the interface, and thereby the refraction property, is adjustable by adjusting a voltage applied to the lens. The two fluids are selected such that they together exhibit a mechanical damping which is critical or near critical. A control circuit generates the electric voltage for adjusting the refraction from one value to another, the control circuit being arranged to change the electric voltage such that a rate of voltage change is limited to avoid oscillation of the interface, thereby adjusting refraction of incoming waves at the interface in a continuous manner. This makes it possible to use the lens while it is during adjustment from one refraction value to another, since the interface shape will at all time during the adjustment have a controlled shape. The voltage can be either a continuous voltage or a discrete stepwise (digital) voltage which is just controlled with respect to step size and temporal extension of the steps. The lens system has a number of applications e.g. within the medical field, e.g. for ‘on the fly’ high speed ultrasound imaging, or for ultrasound ablation applications where ablation can be performed during adjustment of the lens to follow a pre-defined trajectory. | 10-14-2010 |
20120004547 | MONITORING APPARATUS FOR MONITORING AN ABLATION PROCEDURE - The present invention relates to a monitoring apparatus ( | 01-05-2012 |
20120287750 | IMAGING APPARATUS - The invention relates to an imaging apparatus ( | 11-15-2012 |
20130131511 | ULTRASONIC SHEAR WAVE IMAGING WITH FOCUSED SCANLINE BEAMFORMING - An ultrasonic diagnostic imaging system produces an image of shear wave velocities by transmitting push pulses to generate shear waves. A plurality of tracking lines are transmitted and echoes received by a focusing beamformer adjacent to the location of the push pulses. The tracking lines are sampled in a time-interleaved manner. The echo data acquired along each tracking line is processed to determine the time of peak tissue displacement caused by the shear waves at points along the tracking line, and the times of peaks at adjacent tracking lines compared to compute a local shear wave velocity. The resultant map of shear wave velocity values is color-coded and displayed over an anatomical image of the region of interest. | 05-23-2013 |
20130317362 | SHEAR WAVE VELOCITY ESTIMATION USING CENTER OF MASS - The weighted-average-based position ( | 11-28-2013 |
20140088418 | FUNCTIONAL-IMAGING-BASED ABLATION MONITORING - Functional imaging for localization in biological tissue entails measuring a response in the tissue ( | 03-27-2014 |
Patent application number | Description | Published |
20080274258 | Whole Fruit Extracts from the Fruits of the Curcubitaceae Family and Uses Thereof - The present invention provides a method of preparing whole fruit extract from the fruits of the Curcubitaceae family. The method includes extracting the peel and pulp of whole fruits by boiling water. In one embodiment, there is provided Luo Han Guo whole fruit extract. The resulting whole fruit extract can be formulated into a sugar-free or no sugar added, low calorie, low glycemic index syrup or jam comprising, e.g. the Luo Han Guo whole fruit extract and sugar alcohols (polyols). | 11-06-2008 |
20090162511 | NATURAL SWEETNER COMPRISING POWDERED LUO HAN GUO WHOLE FRUIT EXTRACTS - The present invention provides a natural sweetener composition comprising powdered extracts of Luo Han Guo whole fruits, mogrosides, and one or more dietary fiber. In one embodiment, extracts obtained from Luo Han Guo whole fruits are first made into powder form. Mogrosides and/or mogroside-V are then added to the powder extract, which is further formulated with dietary fiber such as inulin into a natural sweetener composition. | 06-25-2009 |
20090162529 | NATURAL SWEETENER COMPRISING POWDERED LUO HAN GUO WHOLE FRUIT EXTRACTS - The present invention provides a natural sweetener composition comprising powdered extracts of Luo Han Guo whole fruits, mogrosides, and one or more dietary fiber. In one embodiment, extracts obtained from Luo Han Guo whole fruits are first made into powder form. Mogrosides and/or mogroside-V are then added to the powder extract, which is further formulated with dietary fiber such as inulin into a natural sweetener composition. | 06-25-2009 |
20100022462 | APPETITE SUPPRESSANT AND COLON CLEANSING COMPOSITION - The present invention provides low calorie, high potency, sugar free compositions and methods for making and using the same. In one embodiment, the composition of the present invention can be used to reduce daily food intake and facilitate detoxification and weight loss. | 01-28-2010 |
Patent application number | Description | Published |
20080319027 | Composition and Method for Treating Fibrotic Diseases - The present invention discloses 5-methyl-1-(substituted phenyl)-2(1H)-pyridones have enhanced anti-fibrotic activities than 5-methyl-1-(non-substituted phenyl)-2(1H)-pyridones. An representative example of 5-methyl-(1-substituted phenyl)-2(1H)-pyridones is 1-(3′-fluorophenyl)-5-methyl-2(1H)-pyridone. Accordingly, there are provided compositions comprising one or more compounds selected from the group consisting of 5-methyl-1-(substituted phenyl)-2(1H)-pyridones and methods of using the same to treat or prevent fibrosis diseases. | 12-25-2008 |
20090005424 | Composition and Method for Treating Fibrotic Diseases - The present invention discloses 5-methyl-1-(substituted phenyl)-2(1H)-pyridones have enhanced anti-fibrotic activities than 5-methyl-1-(non-substituted phenyl)-2(1H)-pyridones. An representative example of 5-methyl-(1-substituted phenyl)-2(1H)-pyridones is 1-(3′-fluorophenyl)-5-methyl-2(1H)-pyridone. Accordingly, there are provided compositions comprising one or more compounds selected from the group consisting of 5-methyl-1-(substituted phenyl)-2(1H)-pyridones and methods of using the same to treat or prevent fibrosis diseases. | 01-01-2009 |
20090258911 | COMPOSITION AND METHOD FOR TREATING FIBROTIC DISEASES - The present invention discloses 5-methyl-1-(substituted phenyl)-2(1H)-pyridones have enhanced anti-fibrotic activities than 5-methyl-1-(non-substituted phenyl)-2(1H)-pyridones. An representative example of 5-methyl-(1-substituted phenyl)-2(1H)-pyridones is 1-(3′-fluorophenyl)-5-methyl-2(1H)-pyridone. Accordingly, there are provided compositions comprising one or more compounds selected from the group consisting of 5-methyl-1-(substituted phenyl)-2(1H)-pyridones and methods of using the same to treat or prevent fibrosis diseases. | 10-15-2009 |
20100099719 | COMPOSITION AND METHOD FOR TREATING PROTEINURIA - The present invention discloses 5-methyl-1-(substituted phenyl)-2(1H)-pyridones having the ability to reduce proteinuria and for treating kidney diseases. The ability to reduce proteinuria has a renoprotective effect for slowing the progression of kidney diseases. A representative example of 5-methyl-(1-substituted phenyl)-2(1H)-pyridones is 1-(3′-fluorophenyl)-5-methyl-2(1H)-pyridone, AKF-PD. Accordingly, the present invention provides compositions comprising one or more compounds selected from the group consisting of 5-methyl-1-(substituted phenyl)-2(1H)-pyridones and methods of using the same to treat proteinuria and kidney diseases. | 04-22-2010 |
Patent application number | Description | Published |
20090073450 | Apparatus and Methods Using Highly Optically Dispersive Media - Embodiments of the invention pertain to the optical phenomena of ‘slow-light’ and ‘fast-light’, provided by a highly optically dispersive medium; that is, one in which the absolute value of the group index of refraction of the medium is equal to or greater than four. Apparatus embodiments of the invention are directed to an optical spectroscopic parameter detection and/or measurement apparatus. In various non-limiting aspects, the apparatus may be in the form of an interferometer, a spectral interferometer, a spectrometer, a wavemeter, a tunable narrowband filter, and other such devices. Various non-limiting, exemplary apparatus may include a two-beam interferometer, a multiple-beam interferometer, a grating-based interferometer/spectrometer, a Fourier-Transform interferometer, and others. The embodied devices include a highly dispersive medium that appropriately can facilitate either a slow-light effect or a fast-light effect, which is disposed in a propagation path of an electromagnetic (EM) input field and, a detector disposed in a manner to detect an output field resulting from the input filed interaction with the highly dispersive medium. Method embodiments involve measuring a spectroscopic parameter with significantly enhanced bandwidth and/or sensitivity and/or resolving power and/or accuracy over currently available measurement techniques, using an embodied optical spectroscopic parameter detection and/or measurement apparatus that incorporates a highly dispersive medium. | 03-19-2009 |